TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 242 filers reported holding TG THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,081 | +1045.2% | 165,414 | +672.4% | 0.66% | +804.1% |
| Q1 2023 | $531 | -90.3% | 21,415 | -20.3% | 0.07% | -91.2% |
| Q4 2022 | $5,498 | -99.9% | 26,856 | -98.2% | 0.83% | -48.6% |
| Q3 2022 | $10,696,000 | +677.9% | 1,469,283 | +3015.0% | 1.62% | +562.0% |
| Q2 2022 | $1,375,000 | -70.7% | 47,168 | -5.5% | 0.24% | -68.1% |
| Q1 2022 | $4,690,000 | -3.3% | 49,926 | +1318.4% | 0.77% | -7.0% |
| Q4 2021 | $4,848,000 | -5.9% | 3,520 | -91.3% | 0.83% | +32.5% |
| Q3 2021 | $5,151,000 | +172.7% | 40,321 | +49.8% | 0.62% | +184.9% |
| Q2 2021 | $1,889,000 | +22.6% | 26,923 | -15.8% | 0.22% | -19.5% |
| Q1 2021 | $1,541,000 | -5.9% | 31,975 | +1.6% | 0.27% | +37.4% |
| Q4 2020 | $1,637,000 | – | 31,473 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 5,434,783 | $60,326,000 | 5.25% |
| RA Capital Management | 9,880,323 | $109,672,000 | 3.33% |
| BRIDGER MANAGEMENT, LLC | 1,907,492 | $21,173,000 | 1.53% |
| Eversept Partners, LP | 776,323 | $8,617,185 | 1.52% |
| Opaleye Management Inc. | 579,651 | $6,434,000 | 1.26% |
| Sofinnova Investments, Inc. | 811,292 | $9,006,000 | 0.65% |
| Ikarian Capital, LLC | 316,200 | $3,510,000 | 0.57% |
| ARMISTICE CAPITAL, LLC | 800,000 | $8,880,000 | 0.51% |
| 683 Capital Management, LLC | 398,271 | $4,421,000 | 0.51% |
| Frontier Wealth Management LLC | 196,750 | $2,184,000 | 0.35% |